Head to Head Contrast: Integra LifeSciences (NASDAQ:IART) vs. InspireMD (NYSE:NSPR)

InspireMD (NYSE:NSPR) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends.

Valuation and Earnings

This table compares InspireMD and Integra LifeSciences”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$6.20 million	12.22	-$19.92 million	($0.75)	-3.87
Integra LifeSciences	$1.54 billion	1.22	$67.74 million	($0.09)	-270.64

Integra LifeSciences has higher revenue and earnings than InspireMD. Integra LifeSciences is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

44.8% of InspireMD shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 29.7% of InspireMD shares are held by insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for InspireMD and Integra LifeSciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0	0	2	0	3.00
Integra LifeSciences	3	4	1	0	1.75

InspireMD presently has a consensus target price of $4.75, suggesting a potential upside of 63.51%. Integra LifeSciences has a consensus target price of $23.00, suggesting a potential downside of 5.58%. Given InspireMD’s stronger consensus rating and higher probable upside, research analysts plainly believe InspireMD is more favorable than Integra LifeSciences.

Risk and Volatility

InspireMD has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Integra LifeSciences has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500.

Profitability

This table compares InspireMD and Integra LifeSciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Integra LifeSciences	-0.42%	12.35%	4.82%

Summary

Integra LifeSciences beats InspireMD on 8 of the 14 factors compared between the two stocks.

About InspireMD

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

About Integra LifeSciences

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.